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Materials and Methods 
Plasmid construction 
The PhiC31-Neo-ins-5xTetO-pEF-H2B-Citrine-ins reporter construct (Fig. 1B) was 
assembled using a backbone containing the PhiC31 attB site, a neomycin resistance gene, 
and a multiple cloning site flanked by two 1.2kb chicken HS4 insulators (16) on each side 
(phiC31-Neomycin-2xcHS4ins-MCS-2xcHS4ins). Three elements of the reporter were 
PCR amplified from the following sources: five Tet binding sites from the TRE-tight 
plasmid (Clontech), pEF from pEF/FRT/V5-Dest (Life Technologies), and H2B-citrine 
from pEV2-12xCSL-H2B-Citrine (36). These components were first sequentially cloned 
into the pExchange1 backbone using standard molecular biology techniques. The entire 
TRE-pEF-H2B-citrine was then PCR-amplified and combined by Gibson assembly with 
the phiC31-Neomycin-2xcHS4ins-MCS-2xcHS4ins backbone cut by AvrII. This 
construct was designed such that after integration, the neomycin gene would be expressed 
from a PGK promoter situated upstream of the phiC31 site in the HAC (16). The PhiC31 
integrase was a gift from the Oshimura Lab (16). 
The plasmids containing the rTetR-CR fusions were built using Gibson assembly of the 
pExchange1 backbone containing the pEF promoter (cut with BamHI and KpnI), H2B-
mCherry (PCR-amplified from a derivative of pEV-12xCSL-H2B-mCherry (36)), rTetR 
(PCR-amplified from rtTA3 system, Clontech), and a PCR product for each CR. The 
source plasmids encoding the CRs were as follows: pCMV-HA-EED (Addgene 24231), 
HDAC4 Flag (Addgene 13821), DNMT3B cDNA (isoform 5, OpenBiosystems 
MMM1013-99827219), and PSV40-E-KRAB-pA (pWW43 (37), a gift from Martin 
Fussenegger). 
 
Cell line construction 
The reporter line was created by integrating the H2B-citrine reporter site-specifically in 
an artificial chromosome (MI-HAC) in CHO-K1 cells (16). This system has several key 
advantages that make it ideal for single-cell analysis of gene expression dynamics during 
CR recruitment and release. Since CHO-K1 cells form a monolayer with well-separated 
nuclei, they are amenable to long-term time-lapse imaging for up to ~5 days, allowing us 
to characterize silencing and reactivation events in single cells. In addition, they can be 
passaged for more than 30 days, allowing long-term measurements of epigenetic 
memory. The MI-HAC lacks endogenous genes, thus minimizing unknown interactions 
between our reporter and other genes. Moreover, the MI-HAC can be transferred to 
different cell lines by microcell-mediated chromosome transfer (MMCT) (16), allowing 
one to quantify the effect of cell type on the dynamics of silencing and reactivation, while 
maintaining a constant genetic context. 
Integration of the reporter was performed by co-transfecting 600 ng PhiC31-Neo-ins-
5xTetO-pEF-H2B-Citrine-ins reporter plasmid and 200 ng PhiC31 integrase plasmid, 
using Lipofectamine 2000 (Invitrogen). The transfection was performed in 24-well plates. 
Cells were transferred to 6-well plates 24 hours later and selected with 400 ng/ul 
geneticin for 12 days, starting 40 hours after the transfection. Single clones were obtained 
by limiting dilution. The integration of the reporter in the HAC was verified by genomic 
PCR, and a single clone was chosen for further analysis.  
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Each of the CR plasmids (pEF-H2B-mCherry-T2A-rTet-CR) was randomly integrated 
into this reporter line by transfection with Lipofectamine 2000 (Invitrogen). These cells 
were selected using 300 µg/ml zeocin starting 24 hours after transfection for a total of 12 
days. Finally, single clones were selected for each CR by limiting dilution.  
Other Chromatin Regulators 
In addition to the CRs presented in the main text (EED, KRAB, DNMT3B and HDAC4), 
we have also tested: EZH2, REST, HDAC3 and RNF2 (RING1B) (Fig. S12). For both 
EZH2 (part of PRC2) and REST, we observe all-or-none silencing of most cells after 5 
days of recruitment. We did not observe any silencing upon HDAC3 recruitment, and 
very little silencing with RNF2. 
Culture conditions 
Cells were cultured at 37ºC, in a humidified atmosphere with 5% CO2. For all 
experiments, except movies, the growth media consisted of Alpha MEM Earle's Salts 
(9144, Irvine Scientific) with 10% Tet Approved FBS (Clontech Laboratories) and 1X 
Penicillin/Streptomycin/L-glutamine (Life Technologies) added. Media containing the 
appropriate antibiotics (300 µg/ml neomycin and 300 µg/ml zeocin) were changed every 
2-3 days during maintenance. During movies, cells were grown in low-fluorescence 
imaging media (36), which consisted of Alpha-MEM without phenol red, riboflavin, folic 
acid, and vitamin B12 (Life Technologies, custom made), supplemented with 10% FBS 
and 1X Pen/Strep/L-glutamine. During all recruitment and de-recruitment experiments, 
media without neomycin or zeocin were used and changed every 24 hours in all wells. 
Cells were harvested by rinsing with Dulbecco's Phosphate-Buffered Saline (DPBS, Life 
Technologies), and incubating at room temperature with 0.25% Trypsin (Life 
Technologies). For long-term storage, cells were frozen in growth media with 10% 
DMSO, placed at -80ºC (for up to a month), and then transferred to liquid nitrogen. 
 
Acquisition of time-lapse movies 
Reporter cells expressing each of the four CRs were plated approximately 12 hours 
before imaging, at low density (1,500 cells/cm
2
) on glass-bottom plates (MatTek) coated 
with 5 µg/ml hamster fibronectin (Oxford Biomedical Research). Imaging was done 
using an inverted Olympus IX81 fluorescence microscope with Zero Drift Control 
(ZDC), a 20X dry objective, and an iKon-M CCD camera (Andor, Belfast, NIR). 
Fluorophores were excited using an X-Cite XLED1 light source (Lumen Dynamics). 
Images were automatically acquired every 20 minutes, using Metamorph software 
(Molecular Devices). The microscope was enclosed in a chamber kept at 37ºC and 5% 
CO2, and the imaging growth media (see Culture conditions) was changed daily. 
Silencing movies began with reporter cells actively expressing the reporter gene. Dox (1 
µg/ml) was added to the cells at ~20 hours, after which imaging continued for at least 3 
more days and until cell tracking became difficult due to high cell density. Cells were 
then re-plated at low density, in the presence of dox, for the subsequent acquisition of 
reactivation movies. Imaging began with these cells ~12 hours after re-plating, and dox 
was washed-out at ~20 hours into the movies (5 days since the beginning of dox 
addition).  
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Analysis of time-lapse data and silencing event detection  
Cells were segmented and tracked using the mCherry fluorescence signal with custom 
Matlab code (available upon request), as follows: (1) Initially, images were processed to 
correct for inhomogeneous fluorescent illumination by fitting a paraboloid to background 
(non-cell) pixel intensities, and then normalizing the image by this paraboloid. (2) We 
then used an integrated segmentation and tracking procedure which combined (a) a pixel-
based intensity threshold for segmentation, (b) a tracking algorithm based on global 
minimization of a cost function that incorporates cell positions and fluorescence 
intensities, and (c) heuristics that use discontinuities in tracking to correct segmentation. 
(3) Finally, all individual cell lineages were checked and corrected manually. 
 
Using the contours obtained from this algorithm, total Citrine fluorescence levels were 
extracted for each of the cell lineages. Since the H2B-Citrine protein is stable, total 
fluorescence levels increased at a steady rate when the reporter was expressed at a 
constant level (Fig. 1C, ‘-dox’), but remained constant (flat) when the reporter gene was 
silenced. At each cell division, the total fluorescence signal was approximately halved as 
fluorescent protein molecules partitioned between daughter cells (38). We 
computationally restored the fluorescence lost during these division events by computing 
the lost fluorescence and adding this constant value to all subsequent time points after a 
division event. This procedure, repeated for all division events, generated the cumulative 
total fluorescence traces (Fig. 1C, solid line), from which reporter production rates were 
assessed (slope of solid line in Fig. 1C). 
To detect silencing events, a threshold on reporter production rate was set for each 
individual lineage at 50% of its median before dox addition (Fig. S3A). To avoid mis-
identification of silencing events due to fluctuations in gene expression levels, a cell was 
marked silent when its reporter production rate dropped and remained below this 
threshold for at least 12 hours.  
Reactivation events were identified when the reporter production rate of a silent cell 
increased beyond a global threshold, and remained above this threshold for at least 12 
hours (Fig. S6). This global threshold was set at 50% of the median reporter production 
rate of all cells before the initial dox addition. The rationale for using a global threshold 
instead of a lineage-specific threshold for reactivation movies is that cells start these 
movies at zero production rate and in many cases do not reactivate during the movie. As 
a result, for many lineages, there is no natural lineage-specific threshold. 
ChIP-qPCR and MeDIP-qPCR 
Each cell line was treated with dox (1µg/ml) for 0, 3, 5, and 11 days before harvesting. 
ChIP and MeDIP were performed using LowCell# ChIP and MagMeDIP kits, 
respectively, with the Bioruptor sonicator (all from Diagenode). For ChIP, we used the 
following antibodies: anti-H3K27me3 (Milipore, 07-449), anti-H3K9me3 (Abcam, 
ab8898), anti-acetyl-H3 (Millipore, 06-599), anti-H3K4me3 (Abcam, ab8580). For 
MeDIP, we used the 5-methylcytidine antibody from the MagMeDIP kit (Diagenode). 
qPCR was performed using SsoFast EvaGreen Supermix on a CFX96-C1000 Real-Time 
PCR System (both from Bio-Rad Laboratories). For qPCR primer sequences, see Table 
S1.  
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Reported fold-enrichment values from qPCR experiments used a standard ∆∆𝐶𝑡 method. 
Here, we denote the threshold cycle number for amplification of a given locus in an 
experiment involving chromatin regulator CR as 𝐶𝑡(𝑙𝑜𝑐𝑢𝑠, 𝐶𝑅). In a first step, we 
normalized by an internal positive control locus for that particular modification, denoted 
𝐶𝑡(𝑐𝑜𝑛𝑡𝑟𝑜𝑙, 𝐶𝑅) (see below for choice of control locus for each modification). Second, 
we normalized this value by the ∆𝐶𝑡 between the locus of interest and the control locus in 
the parental cell line without any CR: 
𝑓𝑜𝑙𝑑 − 𝑐ℎ𝑎𝑛𝑔𝑒 =
2{𝐶𝑡(𝑙𝑜𝑐𝑢𝑠,𝐶𝑅)−𝐶𝑡(𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝐶𝑅)}
2{𝐶𝑡(𝑙𝑜𝑐𝑢𝑠,𝑝𝑎𝑟𝑒𝑛𝑡𝑎𝑙)−𝐶𝑡(𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝑝𝑎𝑟𝑒𝑛𝑡𝑎𝑙)}
 
The internal control loci account for variations in the amount of DNA and pull-down 
efficiency for each sample. For this purpose we selected β-actin for the marks associated 
with active genes (H3K4me3 and histone acetylation) and Igf2 for the silencing marks 
(H3K27me3, H3K9me3, and 5mC). Igf2 was chosen for its lack of expression in mouse 
adult ovary cells (MGI Ref. ID J:46439) and elevated levels of H3K9me3 and 
H3K27me3 implicated in the imprinting of the locus (39). 
 
Flow cytometry for epigenetic memory analysis 
For each cell line, cells were plated in multiple wells at the same time, and either treated 
with dox (1 µg/ml) starting at different times (1, 2, 3, and 5 days before dox removal), or 
grown in the absence of dox (for background silencing correction). Dox was removed 
simultaneously from all samples. At different time points following dox removal, cells 
were harvested using 0.25% Trypsin (Life Technologies). A fraction of the cells (varying 
between one half to one tenth, depending on cell density) were re-plated for the next time 
point. The rest of the cells were resuspended in flow buffer (Hank's Balanced Salt 
Solution (Life Technology) and 2.5 mg/ml BSA), and filtered through 40 μm strainers 
(BD Falcon) to remove clumps. Cellular fluorescence distributions were measured with a 
MACSQuant VYB flow cytometer (Miltenyi Biotec, Bergisch Gladbach, Germany). The 
resulting data were analyzed with a custom Matlab program called EasyFlow (available 
upon request). Single cells were selected based on side and forward scatter properties, 
and only mCherry-expressing cells were analyzed. A manual gate was imposed on the 
Citrine fluorescence to determine the percent of silent cells for each sample (Fig. 2C and 
S7A-C). The gate was selected to contain 1-2% of the positive Citrine peak of untreated 
cells.  
 
Background silencing correction for long-term experiments 
In all cell lines containing CRs, we noticed an increase in the percentage of silent cells 
over 30 days, even in the absence of dox treatment (Fig. S7D). This background silencing 
is a combination of spontaneous silencing of the reporter locus (as seen in the parental 
line with no CRs, Fig. S7D), and non-specific silencing of the reporter by each rTet-CR 
fusion in the absence of dox (likely by dox-independent binding of rTetR to DNA). In 
order to correct for this background silencing, for each cell line, we subtracted the 
fraction of cells silenced in the untreated line and normalized by the fraction of untreated 
cells that were active at each time point. This allowed us to obtain the fraction of cells 
that were silenced specifically by CR recruitment: 
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𝐶𝑆(𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑) =
𝐶𝑆(𝑑𝑜𝑥 𝑡𝑟𝑒𝑎𝑡𝑒𝑑)−𝐶𝑆(𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑)
𝐶𝐴(𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑)
, 
where 𝐶𝑆(𝑑𝑜𝑥 𝑡𝑟𝑒𝑎𝑡𝑒𝑑) and 𝐶𝑆(𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑) are the fraction of cells silenced in the dox 
treated and untreated samples, respectively, and 𝐶𝐴(𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑) is the fraction of cells 
active in the untreated sample at the same time point. 
 
Extracting the transition rates  
During EED and KRAB recruitment, using the model presented in Fig. 3A (upper panel), 
with an initial condition in which all cells are active, the exact solutions for the time 
evolution of the fraction of cells active (𝐶𝐴), reversibly silent (𝐶𝑅), and irreversibly silent 
(𝐶𝐼) are: 
𝐶𝐴(𝑡) =
1
𝛾2 − 𝛾1
[(𝑘𝐴 + 𝑘𝐼 − 𝛾1)𝑒
−𝛾1𝑡 − (𝑘𝐴 + 𝑘𝐼 − 𝛾2)𝑒
−𝛾2𝑡]  
 𝐶𝑅(𝑡) =
𝑘𝑆
𝛾2−𝛾1
[𝑒−𝛾1𝑡 − 𝑒−𝛾2𝑡] (Eq. 1) 
𝐶𝐼(𝑡) = [1 −
𝑘𝑆𝑘𝐼
𝛾1(𝛾2 − 𝛾1)
𝑒−𝛾1𝑡 +
𝑘𝑆𝑘𝐼
𝛾2(𝛾2 − 𝛾1)
𝑒−𝛾2𝑡]  
where 𝑘𝑆, 𝑘𝐴, and 𝑘𝐼 are the rates of silencing, reactivation, and irreversible commitment, 
respectively. We have also defined: 
𝛾1 =
𝑘𝑆+𝑘𝐴+𝑘𝐼−√(𝑘𝑆+𝑘𝐴+𝑘𝐼)2−4𝑘𝑆𝑘𝐼
2
 , 𝛾2 =
𝑘𝑆+𝑘𝐴+𝑘𝐼+√(𝑘𝑆+𝑘𝐴+𝑘𝐼)2−4𝑘𝑆𝑘𝐼
2
. 
Note that the total fraction of cells silent is the sum of cells that are reversibly and 
irreversibly silent: 𝐶𝑆(𝑡) = 𝐶𝑅(𝑡) + 𝐶𝐼(𝑡). 
Additionally, during recruitment, we experimentally observed a time lag between dox 
addition and the onset of silencing, which we denote 𝑇𝑙𝑎𝑔_1. Therefore, for fitting 
purposes, in the equations above, 𝑡 becomes 𝑡 −  𝑇𝑙𝑎𝑔_1 for recruitment times larger than 
𝑇𝑙𝑎𝑔_1. We assume the fractions of silent/active cells are constant before 𝑇𝑙𝑎𝑔_1.  
During EED and KRAB release, we assume that the rates of silencing and irreversible 
commitment are negligible (Fig. 3A, lower panel). This means that the fraction of cells 
silent after CR release (dots in Fig. 3C-F) decays exponentially at a constant rate (𝑘𝐴). 
More specifically, defining 𝐶𝑆(𝑡, 𝜏) as the fraction of cells silenced after a recruitment 
period of duration 𝑡, and release time 𝜏, we have: 
 𝐶𝑆(𝑡, 𝜏) = 𝐶𝑅(𝑡) ⋅ 𝑒
−𝑘𝐴(𝜏−𝑇𝑙𝑎𝑔_2) + 𝐶𝐼(𝑡) (Eq. 2) 
where 𝐶𝑅(𝑡) and 𝐶𝐼(𝑡) are the fraction of cells in the R and I states, respectively, at the 
end of recruitment, and 𝑇𝑙𝑎𝑔_2 is the time lag before reactivation starts.  
For EED and KRAB, the silencing and reactivation data at a given dox concentration 
were fit simultaneously using Equations 1 and 2 for silencing and reactivation phases, 
respectively. For maximum dox (1000 ng/ml), these data consist of the fraction of cells 
silent during recruitment (Fig. 1H), and the fraction of cells silent during release for all 
durations of recruitment (Fig. 3C-F). We use the “fit” function in MATLAB to perform a 
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nonlinear least square fit with two independent parameters, 𝑡 and 𝜏, in order to extract 𝑘𝑆, 
𝑘𝐴 , 𝑘𝐼, 𝑘𝐴 , 𝑇𝑙𝑎𝑔_1 and 𝑇𝑙𝑎𝑔_2. The fits are shown as solid lines in Fig. 3C-F and Fig. S9B-
E. The values of the fitted parameters and their 95% confidence intervals for each dox 
concentration are plotted in Fig. 3G-I. 
Note that during silencing at maximum recruitment strength, the rate of silencing (𝑘𝑆) is 
much higher than the rates of reactivation (𝑘𝐴) and irreversible commitment (𝑘I). 
Therefore, the fraction of silent cells over time during recruitment (dots in Fig. 1H) can 
be well-described using an exponential function that only depends on the rate of silencing 
(𝑘𝑆): 
𝐶𝑆(𝑡) =  {
0
1 − 𝑒−𝑘𝑆(𝑡− 𝑇𝑙𝑎𝑔_1)
, for 𝑡 <  𝑇𝑙𝑎𝑔_1
, for 𝑡 ≥  𝑇𝑙𝑎𝑔_1
, 
where 𝑡 is the recruitment duration, and 𝑇𝑙𝑎𝑔_1 is the time lag before the onset of 
silencing. The resulting fits using this approximation are plotted as solid lines in Fig. 1H.  
During HDAC4 recruitment, the fraction of cells silent as a function of recruitment time 
is equal to the fraction of cells reversibly silent, since there is no irreversibly silent state: 
 𝐶𝑆(𝑡) =  𝐶𝑅(𝑡) =  {
0
𝑘𝑆
𝑘𝑆+𝑘𝐴
(1 − 𝑒−(𝑘𝑆+𝑘𝐴)(𝑡− 𝑇𝑙𝑎𝑔_1))
,for 𝑡< 𝑇𝑙𝑎𝑔_1
,for 𝑡≥ 𝑇𝑙𝑎𝑔_1
, (Eq. 3) 
During reactivation, for HDAC4, all cells that were reversibly silenced at the end of the 
recruitment period (𝑡) reactivate at a constant rate (𝑘𝐴): 
 𝐶𝑆(𝑡, 𝜏) = 𝐶𝑅(𝑡) ⋅ 𝑒
−𝑘𝐴𝜏 (Eq. 4) 
The fraction of cells silent during recruitment and after release of HDAC4 were fit 
simultaneously with Equations 3 and 4 using nonlinear least square fitting in MATLAB 
to extract 𝑘𝑆, 𝑘𝐴 , 𝑇𝑙𝑎𝑔_1, and their 95% confidence intervals. 
For DNMT3B, the fraction of cells silent during recruitment is equal to the fraction of 
cells irreversibly silent (since we assume there is no reversible state), and increases with 
time as follows: 
 CS(t) =  CI(t) =  {
0
1 − e−kI(t− Tlag_1)
,for t< Tlag_1
,for t≥ Tlag_1
, (Eq. 5) 
During release, the fraction of cells irreversibly silent is constant across all times post-
dox (𝜏), and only depends on the duration of recruitment, 𝑡: 
 CS(t, τ) = CI(t) (Eq. 6) 
As with the other CRs, for DNMT3B we simultaneously fit the silencing and memory 
data with Equations 5 and 6 to determine a single 𝑘𝐼 and 𝑇𝑙𝑎𝑔_1, along with 95% 
confidence intervals. 
At non-saturating dox concentration, for EED and DNMT3B, which silence slowly, the 
fraction of cells silenced during recruitment was measured only by flow cytometry. For 
KRAB and HDAC4, which silence fast, the fraction of cells silenced during recruitment 
at non-saturating dox concentrations were measured using time-lapse microscopy, as in 
Fig. 1.  
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Supplementary Text 
Connection between molecular and operational models of chromatin-mediated gene 
silencing and reactivation 
The three-state model (Fig. 3A) represents an operational view of chromatin-mediated 
gene expression dynamics that is different from, and complementary to, molecular 
models of chromatin regulation, in which stochastic writing, spreading and erasing of 
chromatin modifications lead to expansion and shrinkage of chromatin domains (9, 40). 
Here, we ask whether the silencing and reactivation dynamics observed here are 
consistent with a previous model of chromatin spreading dynamics (9). To do so, we 
expand the chromatin spreading model described by Hathaway et al (9), by adding a 
direct connection between chromatin state and gene expression. 
In both the model in (9), and our expanded model, the chromatin is represented by an 
array of nucleosomes that can each be in one of two states: modified and unmodified 
(Fig. S10). The dynamics are controlled by three reactions: (1) Nucleation: CR 
recruitment leads to modification of the central nucleosome of the array at a rate 𝑘+. (2) 
Spreading: Modifications can stochastically spread to neighboring nucleosomes at the 
same rate 𝑘+, both in the presence or absence of the CR. (3) Loss: Modifications can be 
lost from any modified nucleosome at a constant rate 𝑘−. The rates 𝑘+ and 𝑘− were 
previously estimated for HP1 recruitment to be 0.176 h
-1
 and 0.117 h
-1
, respectively (9, 
40). Here we choose a nucleosome array length of 51 nucleosomes. This size is beyond 
the average size of experimentally observed domains (9), and big enough to allow the 
simulated domain to spread without boundary effects. Further increase in array size does 
not affect dynamics for the parameters used here. 
To connect this existing chromatin spreading model with gene regulation dynamics, we 
next added an arbitrary threshold, which determines the minimum size of the chromatin 
modification domain in the immediate neighborhood of the promoter required for a gene 
to be silenced. We used a value of 11 nucleosomes for the size of the neighborhood, and 
considered the gene to be silent when at least 4 of these 11 nucleosomes are modified. 
Otherwise it was assumed to be active (Fig. S10B). This particular threshold was chosen 
such that >80% of cells are silenced by 5 days, and reactivate within 30 days, consistent 
with EED dynamics here, and with HP1 dynamics reported in ref. (9).  
Simulations of the model described above show stochastic silencing and reactivation. The 
fraction of silent cells as a function of time during recruitment and release can be well-fit 
by the three-state model described in Fig. 3A, with constant rates 𝑘𝑆, 𝑘𝐴, and 𝑘𝐼 (Fig. 
S10C and D). These results show that, with a simple assumption about the connection 
between the domain size of a modified region and gene expression, the spreading model 
can give rise to the three-state dynamics described in the text. However, we note that it 
currently remains unclear whether silencing dynamics are in fact dominated by chromatin 
modifications spreading. 
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Connection between all-or-none and graded modes of gene expression regulation 
All-or-none stochastic switching of gene expression states can occur at two levels: In this 
paper, we focus on transitions between active and silent chromatin states. However, even 
within an active chromatin state, promoters in general switch stochastically between 
transcriptionally active and inactive states (this phenomenon is called transcriptional 
bursting; see (41) for a review). Here we discuss the connection between these two 
modes of gene regulation and analyze the dynamic regimes that lead to either graded or 
fractional all-or-none responses at the protein level. Using stochastic simulation, we also 
show that chromatin-mediated switching generally produces bimodal protein distributions 
similar to those observed experimentally, but can also produce graded protein level 
distributions in some parameter regimes. 
The two levels of gene regulation, chromatin-mediated switching and transcriptional 
bursting, can be combined in a single model (Fig S11A) (41). In this model, a gene can 
switch between active and silent chromatin states. In the silent chromatin state, the 
promoter is always inactive, so the level of mRNA production is zero. By contrast, the 
active chromatin state is permissive, allowing the promoter to switch between periods of 
active transcription, which produce bursts of multiple mRNA molecules, and periods of 
inactivity (42–44). 
Transitions in chromatin state and transcriptional bursting are associated with different 
timescales. At the transcription level, switching between active and inactive promoter 
states (indicated with rates 𝑘𝑜𝑓𝑓 and 𝑘𝑜𝑛 in Fig. S11A) has been attributed to short-lived 
interactions of transcription factors and core machinery with the promoter, occurring on 
the timescale of seconds to minutes (41). At the chromatin level, our data suggest that 
switching between active and silent chromatin states (indicated with 𝑘𝑆 and 𝑘𝐴, Fig. 3A 
and Fig. S11A) occur on the timescale of hours to days, an order of magnitude slower 
than the timescales involved in transcriptional bursting. 
The timescales of switching can determine the distribution of protein levels at the 
population level. When switching timescales are fast relative to mRNA and protein half-
lives, which is typically the case for transcription factor regulation, the level of protein 
expressed from the gene reaches a steady state unimodal distribution (45). The mean 
value of this distribution depends in a graded manner on the occupancy of the 
transcription factor at the promoter (29, 31). When switching timescales are slow relative 
to mRNA and protein half-lives, as is generally the case for chromatin-mediated 
regulation, one expects bimodal protein distributions. The relative ratio of the two peaks 
in this bimodal distribution depends both on the occupancy of the CR at the promoter, 
and on the time it has been recruited there. 
Based on the parameters measured here for CR-mediated silencing, EED, KRAB, and 
DNMT3B all operate in the slow switching regime that gives rise to bimodal protein 
distributions across various dox concentrations (Fig. S11B-D). HDAC4 shows all-or-
none stochastic silencing at strong recruitment strengths (saturating dox concentrations). 
However, as dox concentrations are decreased, the protein levels distributions shift in a 
graded manner (Fig. S11E).  
To test if all-or-none silencing and reactivation at the chromatin level alone can 
recapitulate reporter protein distributions over various CRs and conditions, we performed 
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stochastic simulations using the combined chromatin and transcription regulation model 
described in Fig. S11A. For these simulations we used the experimentally measured rates 
associated with chromatin-mediated gene switching - 𝑘𝑆, 𝑘𝐴, and 𝑘𝐼 - for each CR across 
different dox concentrations (Fig. 3G-I). To simplify the simulation and limit the source 
of stochastic switching to the chromatin level, we consider the regime in which 𝑘𝑜𝑛 ≫
𝑘𝑜𝑓𝑓. Under this approximation, the promoter is always active within the active 
chromatin state. The mRNA and protein production rates 𝛽𝑚 (100 hr
-1
) and 𝛽𝑝 (200 hr
-1
) 
are chosen such that the resulting mean H2B-Citrine fluorescence levels in the fully 
active state (without dox) from simulations match those obtained in flow cytometry 
experiments. We use the experimentally measured mRNA degradation rate 𝛾𝑚=0.1733 
hr
-1 
(corresponding to a half-live of 4 hours, as shown in Fig. S2B). We assume that the 
number of molecules for each mRNA and protein species is halved at every cell division 
(dilution). Since H2B-citrine is stable, we set the protein degradation to zero. Lastly, each 
simulated cell has its cell cycle length drawn randomly from a normal distribution with 
mean and variance derived from those empirically observed in movie experiments. 
Stochastic simulation of the model in this regime recapitulated bimodal responses of 
EED, KRAB and DNMT3B (Fig. S11F-H), reflecting the fact the lifetime of the silent 
state remains longer than the protein and mRNA lifetimes, regardless of dox 
concentrations. The model also recapitulated the graded response of HDAC4 observed at 
sub-saturating dox concentrations (Fig. S11I), reflecting the fact that in these conditions 
𝑘𝑆 and 𝑘𝐴 are similar, resulting in lifetimes of the silent state that are on the order of 
protein dilution (i.e. cell division time). Together, these results demonstrate how a 
stochastic, all-or-none model of chromatin-mediated silencing and reactivation is 
sufficient to explain the protein distributions obtained for all four CRs.  
  
11 
 
 
Fig. S1. Recruitment of rTetR alone does not repress gene expression.  
To test whether recruitment of rTetR alone (without an attached CR fusion) affects 
reporter expression, we measured Citrine fluorescence levels in reporter cells stably 
expressing pEF-H2B-mCherry-T2A-rTetR. (A) Schematic of the cell line. (B) Flow 
cytometry shows identical fluorescence distributions in the absence of dox (dashed line) 
and after 33 hours of dox induction (continuous line), indicating that rTetR recruitment 
alone does not repress gene expression.  
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Fig. S2. Timescales for detecting silencing and reactivation events, and reporter 
mRNA lifetime.  
(A) In order to estimate the response time to rTetR recruitment and de-recruitment, we 
built a separate cell line containing the rTetR domain alone recruited to a CMV promoter 
followed by 2xTetO sites (top cartoons). In this case, binding of rTetR directly represses 
expression by acting as a transcription roadblock. We measured changes in reporter 
production rates using time-lapse microscopy. We calculated the mean Citrine production 
rate (see Fig. 1C) as a function of time (black curve) by averaging over single-cell traces 
at each time point. Since cells were dividing, the number of traces analyzed for each time 
point varied between 62 cells (first time point) to 926 cells (last time point). The gray 
shaded curves represent SEM. Addition of dox resulted in a reduction in gene expression 
within 8±2 hours (red arrows). Removal of dox relieved this repression within 2.5±2 
hours (green arrows). (B) The half-life of Citrine mRNA was measured by inhibiting 
transcription with actinomycin D (5µg/ml) and following the levels of mRNA as a 
function of time. These values were measured by qPCR and normalized against a 
constant amount of mCherry mRNA spiked in as internal control. By fitting these data to 
an exponential decay (red line), we determined the half-life of the reporter mRNA to be 
3.9 hours (with a 95% confidence interval of [0.9, 4.3] hours).  
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Fig. S3. Event detection, specificity and strength of silencing.  
(A) Silencing events were detected by setting a threshold on the reporter production rate, 
computed as the smoothed time derivative of the cumulative Citrine fluorescence trace 
(cyan curve, same cell lineage as in Fig. 1C). Note that frames immediately adjacent to 
cell division events were unreliable and therefore removed when the raw total 
fluorescence traces were processed to produce cumulative traces, resulting in gaps in the 
trace. For silencing, we calculated the median reporter production rate before dox 
addition, and set a threshold at 50% of this value (dashed line in dox region). When the 
reporter production rate of this lineage crossed this threshold and remained under it for 
≥12 hours, we classified the event as silencing (black circle). (B) Recruitment lead to 
strong silencing for all four factors. Distributions of H2B-citrine production rates before 
dox (black) and after more than 24 hours in dox (colors, each normalized to the 
corresponding median pre-dox production rate), showing that the production rates in most 
silenced cells collapse to a peak around zero. (C) Single-cell traces in the constitutive 
reporter H2B-mCherry channel, of the same cell lineages shown in Fig. 1D and arranged 
in the same order. Traces are vertically offset for clarity. The H2B-mCherry reporter 
showed steady production in all traces, indicating that dox-mediated silencing is likely 
specific to the H2B-Citrine reporter locus rather than a genome-wide effect.  
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Fig. S4. Deviations from all-or-none silencing dynamics.  
Here we plot examples of silencing dynamics that deviated from all-or-none behaviors 
for (A) EED, (B) DNMT3B, and (C) HDAC4. (For KRAB, we observed no deviations). 
In each panel, a representative example trace is shown for each of two types of non-
typical behaviors, with their observed frequencies indicated by percentages relative to all 
traces. First, partial silencing events are defined as traces that show reduced but not fully 
silenced expression. These are defined by a lack of full silencing within 1.5 cell cycles 
after the initial silencing event (middle trace). Second, non-committed silencing events 
are those in which a strong silencing event is followed by a subsequent increase in 
activity (top trace). Circles indicate detected silencing events. For comparison, we also 
plot examples of typical all-or-none silencing events (bottom traces).  
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Fig. S5. Analysis of sister cell correlation during silencing.  
We tabulated the numbers of sister cell pairs originating from an actively expressing 
parent cell, and compared their silencing behavior in the first cell cycle after division of 
the parent cell. For each factor, we measured the number of sister pairs in which both 
sister cells remained active (ON/ON column), only one sister cell was silenced (ON/OFF 
column), and both sister cells were silenced (OFF/OFF column). From these 
observations, we computed the conditional silencing probability of a sister cell given the 
other sister cell is silenced, i.e., 𝑃 (𝑂𝐹𝐹𝑠𝑖𝑠𝑡𝑒𝑟𝑖 |𝑂𝐹𝐹𝑠𝑖𝑠𝑡𝑒𝑟𝑗 ) =  
2∗ 𝑂𝐹𝐹/𝑂𝐹𝐹
2∗ 𝑂𝐹𝐹/𝑂𝐹𝐹 + 𝑂𝑁/𝑂𝐹𝐹
, see 
last column, left bars. We compared this observed conditional silencing probability to the 
expected counterpart, assuming silencing events are stochastic and independent in the 
two sisters. This expected probability and its 95% confidence intervals (last column, right 
bars) were estimated using the same equation on results from a random permutation test 
with 100,000 trials. Note that while the observed probability is higher than the expected 
value for EED, DNMT3B and HDAC4, these observed values were still closer to the 
expected values assuming complete independence, than to the expected value assuming 
complete correlation (P = 1), or complete anti-correlation (P = 0) between sister cells. 
These results suggest a substantial stochastic component in the silencing process.  
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Fig. S6. Detection of reactivation events.  
(A) The cyan curve is the smoothed time derivative of the cumulative fluorescence trace 
for the same lineage shown in Fig. 2A. Reactivation events were detected in a similar 
way as silencing events, but in the opposite direction. The median pre-dox production 
rate from all lineage traces in the silencing movie (Fig. 1) immediately preceding the 
reactivation movie was used to set a single threshold to detect reactivation events (dashed 
line). Reactivation events were defined by an increase in production rate above this 
threshold that was sustained for ≥12 hours. (B) Single-cell traces of the constitutive 
reporter H2B-mCherry channel, of the same cell lineages shown and arranged as in Fig. 
2B, show steady production rates, indicating that reactivation is specific to the H2B-
Citrine reporter locus. Traces are offset for clarity.  
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Fig. S7. Bimodality during reactivation.  
(A to C) Citrine fluorescence distributions as measured by flow cytometry for the (A) 
KRAB, (B) DNMT3B, or (C) HDAC4 cell lines. These plots are comparable to that of 
EED in Fig. 2C. For all CRs, distributions are shown for cells treated with dox for 5 days, 
followed by 7 days of culture without dox (solid lines, blue, red and green), and for cells 
cultured in parallel with no dox (dashed lines). Note that for DNMT3B, the fluorescence 
distribution after 5 days of dox and 7 days post-dox deviates slightly from a bimodal 
distribution: the silent population has a small sub-population with fluorescence above 
background levels (shoulder in red continuous line). The percentage of cells in this outlier 
subpopulation decreases with longer recruitment times, as seen in the curve for 10 days 
of dox treatment (pink). The vertical gray line in each panel represents the threshold used 
to determine the fraction of cells silent. (D) Low rates of background silencing occur 
even in the absence of dox evident as an increase in the fraction of silent cells over time 
in untreated samples (see silent peak of no dox (dotted) lines in A-C). Data from two 
independent biological replicates are shown for each CR. To correct for this background 
silencing effect, we subtracted the fraction of cells silenced in the absence of dox from 
the fraction of cells silenced with dox addition, to generate the plots in Figs. 2D, 3C-F, 
and S9B-E. For each data point we used a corresponding control (no dox background) 
measured on the same day. See Materials and Methods for more details. 
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Fig. S8. Chromatin regulators produce molecularly distinct silent states.  
(A) Experimental strategy: We used chromatin immunoprecipitation (ChIP) and methyl-
DNA immunoprecipitation (MeDIP), followed by qPCR to quantify five common 
chromatin modifications, at the promoter (orange, arrows) and in the gene body (yellow, 
arrows), after different durations of CR recruitment: 0, 3, 5 or 11 days of dox treatment 
(Materials and Methods). qPCR signals were normalized by β-Actin (for active marks) or 
Igf2 (for repressive marks) and plotted as fold-change (mean ± s.d.) relative to the 
parental (reporter only) cell line. (B) Matrix showing how each chromatin regulator 
affected the levels of each modification, following the conventions from (A). As 
expected, each CR promoted its corresponding modification (shaded plots). Additionally, 
recruitment of one CR also led, directly or indirectly, to other modifications: active 
modifications (H3 acetylation and H3K4me3) decreased in all cases, and the repressive 
H3K9me3 modification associated with KRAB also appeared in response to EED and 
DNMT3B recruitment, consistent with previous reports (46–49). By contrast, H3K27me3 
and DNA methylation were more specific to EED and DNMT3B, respectively. As a 
result, although the molecular states produced by individual CRs partially overlapped, 
each CR produced a silent state with a distinct molecular signature (each column is 
unique). 
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Fig. S9. Different CRs maintain their distinct dynamic modes at lower recruitment 
strengths.  
(A) Experimental design: For each CR, cells were induced for 5 days at varying dox 
concentrations (different color arrows, with dox concentrations increasing from green to 
red). The fraction of silent cells was measured by flow cytometry for 30 days following 
CR release (post-dox). (B-E) Examples of reactivation dynamics after recruitment at 
different dox concentrations. The fraction of cells that remain silent after CR release is 
plotted against the time since dox was removed. Dots represent experimental data from at 
least two independent sets of flow cytometry experiments, and lines are fits to these data 
with the models as in Fig. 3C-F. For each CR, the strength of recruitment (i.e. dox 
concentration) controls the fraction of silent cells in a similar manner to the duration of 
recruitment (compare to Fig. 3C-F). Even at lower recruitment strength, EED and KRAB 
show hybrid memory, DNMT3B leads to irreversible silencing, and HDAC4 produces 
reversible silencing.  
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Fig. S10. Spreading of chromatin modifications can lead to stochastic silencing and 
reactivation at constant rates.  
(A) Molecular model of chromatin modifications dynamics, adapted from (9). An array 
of nucleosomes (circles) that can each be in one of two states: unmodified (white), and 
modified (black). Upon recruitment of a CR, the target nucleosome at the center becomes 
modified (left), at a rate 𝑘+. Modifications can stochastically spread to the neighboring 
nucleosomes at the same rate 𝑘+ (middle). These modifications can be lost at a constant 
rate 𝑘− along the array (right). In the simulation, nucleation takes place only during 
recruitment of a CR, while spreading and loss happen both during recruitment and release 
of the CR. (B) In order to connect chromatin states to gene expression, we set an arbitrary 
threshold: during the simulation, the gene is considered silent if 4 or more of the 11 
nucleosomes closest to the target site are modified (left), and active otherwise (right). (C, 
D) The fraction of cells silenced as a function of time during CR recruitment (C) and 
release (D) obtained from a molecular simulation using the model described in (A) and 
(B) are shown in black. For the simulation we used the gain/spreading and loss rates 
estimated in (9): k+=0.176 h
-1
 and k-=0.117 h
-1
. Black dots represent the average for 100 
cells/arrays, and the black lines represent standard deviations over 10 trials. These 
simulated data can be fit by the three-state model shown in Fig. 3A (red lines), with the 
following rates: 𝑘𝑆 = 0.7 𝑑
−1, 𝑘𝐴 = 0.2 𝑑
−1, 𝑘𝐼 = 0.06 𝑑
−1, and lag times before 
silencing 𝑇𝑙𝑎𝑔_1 = 0.15 𝑑, and before reactivation 𝑇𝑙𝑎𝑔_2 = 0 𝑑. These rates are 
comparable to the ones we measure for EED and KRAB silencing and reactivation from 
experimental results. 
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Fig. S11. All-or-none silencing and reactivation can lead to bimodal or graded 
protein distributions that resemble those observed experimentally. 
(A) The three-state chromatin model can be combined with a stochastic transcription 
model by incorporating additional gene expression steps (see “Connection between all-
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or-none and graded modes of gene expression regulation” in Supplementary Text). (B to 
E) Citrine fluorescence distribution as measured by flow cytometry for (B) EED, (C) 
KRAB, (D) DNMT3B, or (E) HDAC4 cell lines. Cells were treated at the indicated dox 
concentrations for five days before measurement, and no release time was allowed 
(unlike the conditions in Fig. S7). Note that in this case the slow dilution of stable 
reporter protein contributes significantly to the observation of intermediate protein levels 
in bimodal distributions. (F to I) Fluorescence distribution of cell populations for (F) 
EED, (G) KRAB, (H) DNMT3B, or (I) HDAC4, simulated using the model in (A) and 
experimentally derived parameters (Fig. 3G-I). 
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Fig. S12. Silencing by other CRs.  
Cells containing different rTetR-CR fusions were induced by dox treatment for 5 days, 
and their fluorescent distributions were measured using flow cytometry. We observed 
bimodal silencing for (A) EZH2 and (B) REST. We observed very little or no silencing 
for (C) RNF2/RING1B and (D) HDAC3, respectively.  
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Table S1. Primers used for ChIP-qPCR and MeDIP-qPCR 
Locus Name Sequence 
pEF (promoter) 
pEF_F_1013ChI
P ACGTATGTCGAGGTAGGCGT 
pEF_R_1013ChI
P CTAGGCACCGGTTCAATTGC 
citrine (gene body) 
F_cit_Set2 
CGGCGACGTAAACGGCCACAAGTTC
AG 
R_cit_Set2 CTTGCCGGTGGTGCAGATGAA 
actin (control) 
bActin F ACTGGGACGATATGGAGAAG 
bActin R GGTCATCTTTTCACGGTTGG 
Igf2 (control) 
5-42_Igf2_F CTGTGGCCTGTAGGTCCTTG 
5-43_Igf2_R CCTCTGCCTTTCCCTCTTGG 
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Movie S1. Highlighted silencing movie for EED; related to movie S5 
Movie S2. Highlighted silencing movie for KRAB; related to movie S6 
Movie S3. Highlighted silencing movie for DNMT3B; related to movie S7 
Movie S4. Highlighted silencing movie for HDAC4; related to movie S8 
Movie S9. Highlighted reactivation movie for EED; related to movie S13 
Movie S10. Highlighted reactivation movie for KRAB; related to movie S14 
Movie S11. Highlighted reactivation movie for DNMT3B; related to movie S15 
Movie S12. Highlighted reactivation movie for HDAC4; related to movie S16 
 
Movies S1-S4 and S9-S12 are zoomed-in views of silencing and reactivation 
respectively, one for each CR. Each movie is digitally cropped and centered on the 
specific cells highlighted in Fig. 1C and 2C (for EED) and on one of the lineages shown 
in Fig. 1D and 2D (for all other factors). Citrine fluorescence is pseudo-colored as 
yellow. All cells segmented (using mCherry fluorescence) are circled in red. We focus on 
one lineage over time by highlighting it with a cyan contour. Only one daughter cell is 
highlighted after each cell division event. Time stamps are in HH:MM relative to dox 
addition (for S1 to S4) or dox removal (for S9 to S12). For the highlighted cells, silencing 
(in S1 to S4) and reactivation events (in S9 to S12) are indicated with thick green circles 
around the focused cells in the few frames at and following the events. See Movies S5 to 
S8 and S13 to S16 for dual-channel, un-cropped versions of these movies.  
 
Movie S5. Full silencing movie for EED;  
Movie S6. Full silencing movie for KRAB;  
Movie S7. Full silencing movie for DNMT3B;  
Movie S8. Full silencing movie for HDAC4;  
Movie S13. Full reactivation movie for EED;  
Movie S14. Full reactivation movie for KRAB;  
Movie S15. Full reactivation movie for DNMT3B;  
Movie S16. Full reactivation movie for HDAC4;  
 
Movies S5-S8 and S13-S16 are representative, full silencing and reactivation movies for 
each of the CRs tested. Citrine and mCherry channels are psuedo-colored as yellow and 
magenta, respectively. Time stamps are relative to dox addition (for S5 to S8) or dox 
removal (for S13 to S16). 
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